Join IceCure’s Live Specialty Webinar on Bone Tumor Cryoablation, Nov. 17th 2020
FOR INTERVENTIONAL ONCOLOGISTS AND ONCOLOGISTS Register here to join this unique webinar on bone tumor cryoablation on Tuesday November 17th at 13:00 CET, in collaboration with the European Institute of Oncology (EIO) in Milan, Italy. We are honored to host Director of the Division of Interventional Radiology at EIO, Franco Orsi, MD, PhD, EBIR, together with Deputy […]
Webinar: Coding, Billing, and Reimbursement for Breast Cryoablation
Webinar on coding, billing and reimbursement for breast tumor cryoablation by Karen Scott. Karen Scott is the sole proprietor of Karen Scott Seminars and Consulting. She has been an educator for many years including teaching in the Health Information Management (HIM) Programs at the University of Tennessee Health Science Center and Arkansas Tech University.
IceCure shares first published results using the Prosense cryoablation system in kidney cancer
“None of the treated tumor lesions demonstrated contrast enhancement or growth on follow up imaging indicating a 100% oncologic success.” The full research was published in the Journal of Molecular and Clinical Medicine and conducted by Bnai Zion Medical Center in Israel by Dr. Sagi Shprits, Dr. Robert Sachner, Prof Ofer Nativ and Dr Sarel […]
COVID-19 Pandemic: Now is the Time to Embrace Healthcare Innovation by Tlalit Bussi
In this article, IceCure’s VP Business Development and Marketing, Tlalit Bussi Tel-Tzure’s discusses healthcare innovation in the time of COVID-19. The healthcare landscape has forever changed – are you ready? Read the full article here!
Online Expert Webinar on Cryoablation of Breast Tumors: Surgeon’s Perspective
Expert meeting session on breast tumor cryoablation from the surgeon’s perspective featuring case studies and insights. Hosted by Prof. Giovanni Paolo Pollini, and featuring Dr. Francesca Pellini and Dr. Richard E. Fine,
Online Expert Webinar on Cryoablation of Breast Tumors: Radiologist Perspective
Breast radiologist and Co-lead Investigator of the landmark ICE3 study for nitrogen-based cryoablation of small, low-risk, early stage malignant breast tumors, Dr. Kenneth Tomkovich in an educational session on breast tumor cryoablation. Watch to learn about the clinical data on the subject with post-cryoablation imaging, and case examples.
ICECURE’S PROSENSE® TUMOR FREEZING PRODUCT APPROVED FOR MARKET IN SOUTH AFRICA
Following IceCure’s accelerating global expansion, the company has received regulatory approval for the treatment of benign and cancerous tumors in many indications including for the breast, lung, bone and kidney. Through their new exclusive partner,Tecmed Africa, IceCure’s technology will lead the field in bringing cryoablation to South Africa. Read more
Online Expert Webinar on Cryoablation of Breast Tumors: Dr. Richard Fine and Izasa Hospital
Watch a live presentation from medical expert, Dr. Richard E. Fine, Director of Education and Research at West Cancer Center & Research Institute, USA, on breast tumor cryoablation, in partnership with Izasa hospital in Spain.
IceCure’s Global Expansion Accelerates; Tumor Freezing Product Now Approved for Market in India
New Indian regulatory approval received for its cryoablation technology to destroy tumors in extensive indications, including for breast, lung, bone and kidney cancer. Read more.
IceCure Enters German Cryoablation Oncology Market; Inks Exclusive Distribution Agreement with MTS Medical Technology
New German Territory Follows Accelerating Global Expansion with Orders in Singapore and Thailand This Month for Its Freezing Technology to Destroy Tumors. Read more.